Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

Macular Degeneration

Health written question – answered on 6th June 2007.

Alert me about debates like this

Photo of John Mann John Mann PPS (Rt Hon Richard Caborn, Minister of State), Department for Culture, Media & Sport

To ask the Secretary of State for Health what treatment is available on the NHS for wet macular eye degeneration.

Photo of Rosie Winterton Rosie Winterton The Minister of State, Department of Health

holding answer 4 June 2007

All primary care trusts (PCTs) are funding photodynamic therapy treatment for patients with both the wholly classic and predominantly classic forms of wet age-related macular degeneration, in line with guidance from the National Institute for Health and Clinical Excellence (NICE).

NICE is currently carrying out an appraisal of Lucentis and Macugen, which are now both licensed for the treatment of wet age-related macular degeneration, and final guidance is due to be published in September 2007.

Where guidance from NICE is not yet available, PCTs are expected to apply local arrangements for the managed introduction of new technologies. These arrangements should include an assessment of the available evidence.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.